Acne vulgaris Trials in Murfreesboro, United States
Conditions / Acne vulgaris / Murfreesboro, United States
Clinical trials for Acne vulgaris investigate a range of treatment strategies and patient populations.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03127956 | A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris | COMPLETED | PHASE3 |
| NCT02604680 | A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris | COMPLETED | PHASE2 |
| NCT02431052 | A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris | COMPLETED | PHASE2 |
| NCT03717506 | Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris | COMPLETED | PHASE3 |
| NCT02682264 | An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris | COMPLETED | PHASE3 |
| NCT03028363 | A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris | COMPLETED | PHASE3 |
| NCT03168334 | A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302) | COMPLETED | PHASE3 |
| NCT02815267 | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne | COMPLETED | PHASE3 |
| NCT04856917 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris | COMPLETED | PHASE2 |
| NCT02608450 | A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) | COMPLETED | PHASE3 |